Advertisement
Screener

INVIVYD, INC. (IVVD) Market Cap

INVIVYD, INC. (IVVD) Market Cap

  • 2026-09-03: Market Cap $244.21M.
  • 2026-07-30: Market Cap $171.55M.
  • 2026-06-30: Market Cap $257.03M.
  • 2026-04-30: Market Cap $412.45M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2021-09-13 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$244.21M
2026-07-30$171.55M
2026-06-30$257.03M
2026-04-30$412.45M
2026-03-31$367.65M
2026-02-26$480.41M
2025-12-31$696.51M
2025-10-30$435.94M
2025-09-30$235.85M
2025-08-01$87.94M
2025-06-30$85.9M
2025-05-01$72.82M
2025-03-31$72.58M
2025-03-11$101.49M
2024-12-31$53.09M
2024-11-01$109.33M
2024-09-30$122M
2024-08-01$142.73M
2024-06-30$131.39M
2024-05-02$282.78M
2024-03-31$529.34M
2024-03-12$431.58M
2023-12-31$434.03M
2023-11-02$170.68M
2023-09-30$186.74M
2023-08-03$162.44M
2023-06-30$115.05M
2023-05-04$129.19M
2023-03-31$131.18M
2023-03-16$175.8M
2022-12-31$163.57M
2022-11-03$389.07M
2022-09-30$341.04M
2022-08-08$427.7M
2022-06-30$356.8M
2022-05-06$315.98M
2022-03-31$500.12M
2022-03-24$460.64M
2021-12-31$804.28M
2021-11-08$2.14B
2021-09-30$4.7B
2021-09-13$4.78B

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49